Answers are grounded in this paper and cite their sources.
A variety of dental and periodontal indices and parameters are used along with radiographs for the purpose of diagnosis and assessment of alveolar bone levels in periodontitis patients. The future research is currently working towards development of objective measures such as biomarkers which can identify and quantify periodontal disease risk and its progression. Biomarkers are used to objectively evaluate normal biologic processes, pathogenic processes and pharmacologic response to therapy protocols. Biomarkers are tell-tale molecules that could be used to monitor health status, disease onset, treatment response and outcome. Biomarkers serve as early surveillance of periodontal disease.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: